{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:19:13Z","timestamp":1781752753548,"version":"3.54.5"},"reference-count":38,"publisher":"Norwegian Medical Association","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2011,11,1]]},"DOI":"10.4045\/tidsskr.10.1454","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T05:30:43Z","timestamp":1320298243000},"page":"2122-5","source":"Crossref","is-referenced-by-count":5,"title":["Misbruk av gammahydroksybutyrat"],"prefix":"10.4045","volume":"131","author":[{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siren","family":"Haugland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Laborit H. Sodium 4-hydroxybutyrate. Int J Neuropharmacol 1964; 3: 432\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14334876&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/0028-3908(64)90074-7","DOI":"10.1016\/0028-3908(64)90074-7"},{"key":"ref=2","unstructured":"Nordmo E. Gravide har mer GHB i urin. Troms\u00f8: RELIS Nord-Norge, 2010."},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Bessman SP, Fishbein WN. Gamma-hydroxybutyrate, a normal brain metabolite. Nature 1963; 200: 1207\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14089913&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/2001207a0","DOI":"10.1038\/2001207a0"},{"key":"ref=4","unstructured":"Hibell B, Guttormsson U, Ahlstr\u00f6m S et al. The 2007 ESPAD Report \u2013 substance use among students in 35 European countries. Stockholm: Espad, 2009."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Galloway GP, Frederick SL, Staggers FE jr. et al. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92: 89\u2009\u2013\u200996. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9060200&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1360-0443.1997.tb03640.x","DOI":"10.1111\/j.1360-0443.1997.tb03640.x"},{"key":"ref=6","unstructured":"KRIPOS. Narkotika- og dopingstatistikk 2009. Oslo: KRIPOS, 2009."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Al-Samarraie MS, Karinen R, M\u00f8rland J et al. Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway. Eur J Clin Pharmacol 2010; 66: 987\u2009\u2013\u200998. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20717656&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00228-010-0870-x","DOI":"10.1007\/s00228-010-0870-x"},{"key":"ref=8","unstructured":"Helland A, Skj\u00f8tskift S. Medikamentell behandling av alkoholabstinens. Tidsskr Nor Legeforen 2008; 128: 1182-4. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18480869&dopt=Abstract"},{"key":"ref=9","unstructured":"Hordvin, O, red. The drug situation in Norway 2010 Annual report to the European Monitoring Centre for Drugs and Drug Addiction \u2013 EMCDDA. Rapport. Oslo: Statens institutt for rusmiddlforskning, (2010) ."},{"key":"ref=10","unstructured":"Hillebrand J, Olszewski D, Sedefov R. GHB and its precursor GBL: an emerging trend case study. Lisboa: EMCDDA, 2008."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Ramo DE, Grov C, Delucchi K et al. Typology of club drug use among young adults recruited using time-space sampling. Drug Alcohol Depend 2010; 107: 119\u2009\u2013\u200927. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19939585&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.drugalcdep.2009.09.014","DOI":"10.1016\/j.drugalcdep.2009.09.014"},{"key":"ref=12","unstructured":"F\u00f8re-Var rapporten juni 2010: Rustrender i Bergen. Bergen: Bergensklinikkene, 2010."},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Hovda KE, Bjornaas MA, Skog K et al. Acute poisonings treated in hospitals in Oslo: a one-year prospective study (I): pattern of poisoning. Clin Toxicol (Phila) 2008; 46: 35\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18167035&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/15563650601185969","DOI":"10.1080\/15563650601185969"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J Psychoactive Drugs 2001; 33: 143\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11476261&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/02791072.2001.10400479","DOI":"10.1080\/02791072.2001.10400479"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Degenhardt L, Darke S, Dillon P. GHB use among Australians: characteristics, use patterns and associated harm. Drug Alcohol Depend 2002; 67: 89\u2009\u2013\u200994. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12062782&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0376-8716(02)00017-0","DOI":"10.1016\/S0376-8716(02)00017-0"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998; 31: 729\u2009\u2013\u200936. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9624313&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0196-0644(98)70232-X","DOI":"10.1016\/S0196-0644(98)70232-X"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Miotto K, Darakjian J, Basch J et al. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict 2001; 10: 232\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11579621&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/105504901750532111","DOI":"10.1080\/105504901750532111"},{"key":"ref=18","unstructured":"GHB. Oslo: Giftinformasjonen, 2007."},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Chin RL, Sporer KA, Cullison B et al. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998; 31: 716\u2009\u2013\u200922. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9624311&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0196-0644(98)70230-6","DOI":"10.1016\/S0196-0644(98)70230-6"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Craig K, Gomez HF, McManus JL et al. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 2000; 18: 65\u2009\u2013\u200970. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10645841&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0736-4679(99)00163-8","DOI":"10.1016\/S0736-4679(99)00163-8"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Thomas G, Bonner S, Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report. BMJ 1997; 314: 35\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9001478&dopt=Abstract","DOI":"10.1136\/bmj.314.7073.35"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001; 63: 1\u2009\u2013\u200922. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11297827&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0376-8716(00)00191-5","DOI":"10.1016\/S0376-8716(00)00191-5"},{"key":"ref=23","unstructured":"Grung M. GHB\/GBL. Kartleggingsrapport i Bergen og omegn 2010. Bergen: Utekontakten i Bergen, Bergen Kommune, Stiftelsen Bergensklinikkene, 2010."},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Mason PE, Kerns WP 2nd. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002; 9: 730\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12093716&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1553-2712.2002.tb02154.x","DOI":"10.1197\/aemj.9.7.730"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Zvosec DL, Smith SW, Porrata T et al. Case series of 226 \u03b3-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med 2011; 29: 319\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20825811&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ajem.2009.11.008","DOI":"10.1016\/j.ajem.2009.11.008"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Kam PC, Yoong FF. Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 1998; 53: 1195\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10193223&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046\/j.1365-2044.1998.00603.x","DOI":"10.1046\/j.1365-2044.1998.00603.x"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate\u2013a drug of abuse. Acta Neurol Scand 2006; 114: 145\u2009\u2013\u200956. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16911342&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2006.00712.x","DOI":"10.1111\/j.1600-0404.2006.00712.x"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Mason PE, Kerns WP 2nd. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002; 9: 730\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12093716&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1553-2712.2002.tb02154.x","DOI":"10.1197\/aemj.9.7.730"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Wojtowicz JM, Yarema MC, Wax PM. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review. CJEM 2008; 10: 69\u2009\u2013\u200974. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18226321&dopt=Abstract","DOI":"10.1017\/S1481803500010034"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37: 147\u2009\u2013\u200953. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11174231&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1067\/mem.2001.112985","DOI":"10.1067\/mem.2001.112985"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Snead OC 3rd, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005; 352: 2721\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15987921&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJMra044047","DOI":"10.1056\/NEJMra044047"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"McDonough M, Kennedy N, Glasper A et al. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004; 75: 3\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15225884&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.drugalcdep.2004.01.012","DOI":"10.1016\/j.drugalcdep.2004.01.012"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Tarabar AF, Nelson LS. The gamma-hydroxybutyrate withdrawal syndrome. Toxicol Rev 2004; 23: 45\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15298492&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00139709-200423010-00005","DOI":"10.2165\/00139709-200423010-00005"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Gonzalez A, Nutt DJ. Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 2005; 19: 195\u2009\u2013\u2009204. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15871147&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177\/0269881105049041","DOI":"10.1177\/0269881105049041"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Rosenberg MH, Deerfield LJ, Baruch EM. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management. Am J Drug Alcohol Abuse 2003; 29: 487\u2009\u2013\u200996. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12765217&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1081\/ADA-120020529","DOI":"10.1081\/ADA-120020529"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Bennett WR, Wilson LG, Roy-Byrne PP. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report. J Psychoactive Drugs 2007; 39: 293\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18159783&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080\/02791072.2007.10400616","DOI":"10.1080\/02791072.2007.10400616"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"LeTourneau JL, Hagg DS, Smith SM. Baclofen and gamma-hydroxybutyrate withdrawal. Neurocrit Care 2008; 8: 430\u2009\u2013\u20093. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18266111&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s12028-008-9062-2","DOI":"10.1007\/s12028-008-9062-2"},{"key":"ref=38","unstructured":"Waal H, Clausen T, H\u00e5seth A et al. (2010). Statusrapport 2009. Senter for rus og avhengighetsforskning. Rapport 1\/2010. Universitetet i Oslo."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:31:54Z","timestamp":1781659914000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2011\/11\/oversiktsartikkel\/misbruk-av-gammahydroksybutyrat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.10.1454","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}